Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11753472 | Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) | David J. King, Srimoyee Ghosh, Baochuan Huang | 2023-09-12 |
| 11732047 | FcRn antibodies and methods of use thereof | David J. King, Leona E. Ling, James Meador, III, Sucharita Roy, Anthony Manning | 2023-08-22 |
| 11352427 | Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3) | David J. King, Jean DA SILVA CORREIA | 2022-06-07 |
| 11345751 | FcRn antibodies and methods of use thereof | Leona E. Ling, Sucharita Roy, Nathaniel J. Washburn, David J. King, Anthony Manning +2 more | 2022-05-31 |
| 11155624 | Antibodies directed against programmed death-1 (PD-1) | David J. King, Baochuan Huang | 2021-10-26 |
| 10836824 | Antibodies directed against lymphocyte activation gene 3 (LAG-3) | Helen Toni Jun, Peter Bowers, David J. King | 2020-11-17 |
| 10738117 | Antibodies directed against programmed death-1 (PD-1) | David J. King | 2020-08-11 |
| 10676526 | FcRn antibodies and methods of use thereof | David J. King, Leona E. Ling, James Meador, III, Sucharita Roy, Anthony Manning | 2020-06-09 |
| 10508149 | Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) | David J. King, Jean DA SILVA CORREIA | 2019-12-17 |
| 10428145 | PD-1 binding proteins and methods of use thereof | Brydon L. Bennett, Philip Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Roli Khattri +5 more | 2019-10-01 |
| 10150817 | Rapid generation of anti-idiotypic antibodies | Robert J. Dunn | 2018-12-11 |
| 9815897 | Antibodies directed against programmed death-1 (PD-1) | David J. King | 2017-11-14 |
| 6297052 | B cell culture system comprising high density membrane bound CD40 ligand | Brian Castle | 2001-10-02 |
| 6143507 | High throughput compatible assay for receptor-TRAF interactions | Steven Pullen, James J. Crute | 2000-11-07 |
| 5817516 | Methods for proliferating and differentiating B cells with high density membrane CD40 ligand | Brian Castle | 1998-10-06 |